Skip to Primary Content
Skip to Footer

About
About Mannkind Our Values Executive Leadership Board of Directors History of Innovation Newsroom
Products & Pipeline
Products & Pipeline Pipeline Chart Clinical Trials About Clinical Trials Mannkind Trials Scientific Advisory Board Publications
Investors
Investing in Mannkind Events & Presentations Corporate Deck & Fact Sheet Press Releases SEC Filings Financial Information Annual Reports Quarterly Results ESG Stock Information Historic Price Lookup Investment Calulator Ownership Profile Analyst Coverage
Partners
Partnering with Mannkind Technosphere Innholation innovation BluHale Inhalation H-Patch Intelectual property
Careers
Mannkind Careers Locations Department Open Positions Benefits Internships & Fellowships

About
Our Values Executive Leadership Board of Directors History of Innovation Newsroom
Products & Pipeline
Pipeline Chart Clinical Trials About Clinical Trials Mannkind Trials Scientific Advisory Board Publications
Investors
Events & Presentations Corporate Deck & Fact Sheet Press Releases SEC Filings Financial Information Annual Reports Quarterly Results ESG Stock Information Historic Price Lookup Investment Calulator Ownership Profile Analyst Coverage
Partners
Technosphere Innholation innovation BluHale Inhalation H-Patch Intelectual property
Careers
Locations Department Open Positions Benefits Internships & Fellowships

News & Events
January 27, 2020

Thomas Blevins, MD, FACE, ECNU, FNLA

Clinical Endocrinologist, Texas Diabetes and Endocrinology, Austin, Texas

previous post
next post

Make a humann connection with us. Reach out anytime.

contact

sign up for email updates

sign up

Terms of Use Privacy Policy Patent Notices Corporate Governance

©2025 MannKind Corporation. All rights reserved.